HRT Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

HRT Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Buy	+45,168	New	+$1.5M	﹤0.01%	1868
2025 Q4	–	Sell	-8,697	Closed	-$301K	–	3483
2025 Q3	$301K	Buy	+8,697	New	+$278K	﹤0.01%	2169
2024 Q4	–	Sell	-16,241	Closed	-$467K	–	2694
2024 Q3	$467K	Buy	+16,241	New	+$442K	﹤0.01%	1617
2021 Q4	–	Sell	-39,608	Closed	-$2.08M	–	3508
2021 Q3	$2.08M	Buy	39,608 +32,436	+452%	+$1.93M	0.01%	707
2021 Q2	$494K	Sell	7,172 -4,322	-38%	-$330K	﹤0.01%	1794
2021 Q1	$886K	Buy	+11,494	New	+$1.06M	0.01%	1270
2020 Q4	–	Sell	-2,760	Closed	-$391K	–	2077
2020 Q3	$391K	Buy	+2,760	New	+$460K	0.01%	1001
2019 Q3	–	Sell	-8,697	Closed	-$1.12M	–	1465
2019 Q2	$1.12M	Buy	+8,697	New	+$1.03M	0.07%	250

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's LKFT Position: Q1 2026 in Review

HRT Financial opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 45,168 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #1868 among its holdings. This is a return to the name: HRT Financial previously reported a position in LKFT as recently as Q3 2025.

HRT Financial first reported a position in LKFT in Q2 2019 and has held it in 8 quarters since. The position peaked at $2.08M in Q3 2021. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

HRT Financial held 45,168 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.35M as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new HRT Financial position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1868 holding.
HRT Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 8 quarters since.
HRT Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.08M in Q3 2021.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.